Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
Psychoneuroendocrinology ; 144: 105868, 2022 10.
Article in English | MEDLINE | ID: mdl-35853381

ABSTRACT

BACKGROUND: Mitochondria are multifunctional energy-producing and signaling organelles that support life and contribute to stress adaptation. There is a growing understanding of the dynamic relationship between stress exposure and mitochondrial biology; however, the influence of stress on key domains of mitochondrial biology during early-life, particularly the earliest phases of intra-uterine/prenatal period remains largely unknown. Thus, the goal of this study was to examine the impact of fetal exposure to stress (modeled as the biological construct allostatic load) upon mitochondrial biology in early childhood. METHODS: In n = 30 children (range: 3.5-6 years, 53% male), we quantified mitochondrial content via citrate synthase (CS) activity and mtDNA copy number (mtDNAcn), and measured mitochondrial bioenergetic capacity via respiratory chain enzyme activities (complexes I (CI), II (CII), and IV (CIV)) in platelet-depleted peripheral blood mononuclear cells (PBMCs). In a cohort of healthy pregnant women, maternal allostatic load was operationalized as a latent variable (sum of z-scores) representing an aggregation of early-, mid- and late-gestation measures of neuroendocrine (cortisol), immune (interleukin-6, C-reactive protein), metabolic (homeostasis model assessment of insulin resistance, free fatty acids), and cardiovascular (aggregate systolic and diastolic blood pressure) systems, as well as an anthropometric indicator (pre-pregnancy body mass index [BMI]). RESULTS: An interquartile increase in maternal allostatic load during pregnancy was associated with higher mitochondrial content (24% and 15% higher CS and mtDNAcn), and a higher mitochondrial bioenergetic capacity (16%, 23%, and 25% higher CI, CII and CIV enzymatic activities) in child leukocytes. The positive association between maternal allostatic load during pregnancy and child mitochondrial content and bioenergetic capacity remained significant after accounting for the effects of key pre- and post-natal maternal and child covariates (p's < 0.05, except CI p = 0.073). CONCLUSION: We report evidence that prenatal biological stress exposure, modeled as allostatic load, was associated with elevated child mitochondrial content and bioenergetic capacity in early childhood. This higher mitochondrial content and bioenergetic capacity (per leukocyte) may reflect increased energetic demands at the immune or organism level, and thus contribute to wear-and-tear and pathophysiology, and/or programmed pro-inflammatory phenotypes. These findings provide potential mechanistic insight into the cellular processes underlying developmental programming, and support the potential role that changes in mitochondrial content and bioenergetic functional capacity may play in altering life-long susceptibility for health and disease.


Subject(s)
Allostasis , Allostasis/physiology , DNA, Mitochondrial , Energy Metabolism , Female , Humans , Leukocytes, Mononuclear/metabolism , Male , Mitochondria/metabolism , Pregnancy
2.
Transl Psychiatry ; 9(1): 218, 2019 09 05.
Article in English | MEDLINE | ID: mdl-31488811

ABSTRACT

Polyamines have fundamental roles in brain homeostasis as key modulators of cellular excitability. Several studies have suggested alterations in polyamine metabolism in stress related disorders, suicide, depression, and neurodegeneration, making the pharmacological modulation of polyamines a highly appealing therapeutic strategy. Polyamines are small aliphatic molecules that can modulate cationic channels involved in neuronal excitability. Previous indirect evidence has suggested that polyamines can modulate anionic GABAA receptors (GABAARs), which mediate inhibitory signaling and provide a direct route to reduce hyperexcitability. Here, we attempted to characterize the effect that spermine, the polyamine with the strongest reported effect on GABAARs, has on human postmortem native GABAARs. We microtransplanted human synaptic membranes from the dorsolateral prefrontal cortex of four cases with no history of mental or neurological disorders, and directly recorded spermine effects on ionic GABAARs responses on microtransplanted oocytes. We show that in human synapses, inhibition of GABAARs by spermine was better explained by alkalization of the extracellular solution. Additionally, spermine had no effect on the potentiation of GABA-currents by diazepam, indicating that even if diazepam binding is enhanced by spermine, it does not translate to changes in functional activity. Our results clearly demonstrate that while extracellular spermine does not have direct effects on human native synaptic GABAARs, spermine-mediated shifts of pH inhibit GABAARs. Potential spermine-mediated increase of pH in synapses in vivo may therefore participate in increased neuronal activity observed during physiological and pathological states, and during metabolic alterations that increase the release of spermine to the extracellular milieu.


Subject(s)
Prefrontal Cortex/drug effects , Receptors, GABA-A/metabolism , Spermine/pharmacology , Synapses/drug effects , Synaptic Membranes/drug effects , Humans , Hydrogen-Ion Concentration , Neurons/drug effects , Neurons/metabolism , Oocytes/drug effects , Oocytes/metabolism , Prefrontal Cortex/metabolism , Synapses/metabolism , Synaptic Membranes/metabolism
4.
Mol Psychiatry ; 21(10): 1342-50, 2016 10.
Article in English | MEDLINE | ID: mdl-26666201

ABSTRACT

Elevated cerebrospinal fluid (CSF) levels of the glia-derived N-methyl-D-aspartic acid receptor antagonist kynurenic acid (KYNA) have consistently been implicated in schizophrenia and bipolar disorder. Here, we conducted a genome-wide association study based on CSF KYNA in bipolar disorder and found support for an association with a common variant within 1p21.3. After replication in an independent cohort, we linked this genetic variant-associated with reduced SNX7 expression-to positive psychotic symptoms and executive function deficits in bipolar disorder. A series of post-mortem brain tissue and in vitro experiments suggested SNX7 downregulation to result in a caspase-8-driven activation of interleukin-1ß and a subsequent induction of the brain kynurenine pathway. The current study demonstrates the potential of using biomarkers in genetic studies of psychiatric disorders, and may help to identify novel drug targets in bipolar disorder.


Subject(s)
Bipolar Disorder/genetics , Kynurenic Acid/metabolism , Psychotic Disorders/genetics , Adult , Aged , Bipolar Disorder/cerebrospinal fluid , Bipolar Disorder/metabolism , Brain/metabolism , Chromosomes, Human, Pair 1/genetics , Cognition Disorders/complications , Cognitive Dysfunction/genetics , Cognitive Dysfunction/metabolism , Female , Genome-Wide Association Study , Humans , Kynurenic Acid/cerebrospinal fluid , Male , Middle Aged , Psychotic Disorders/complications , Psychotic Disorders/metabolism , Sorting Nexins/genetics
5.
Transl Psychiatry ; 5: e636, 2015 Sep 15.
Article in English | MEDLINE | ID: mdl-26371764

ABSTRACT

Stress can be a predisposing factor to psychiatric disorders and has been associated with decreased neurogenesis and reduced hippocampal volume especially in depression. Similarly, in white blood cells chronic psychological stress has been associated with telomere shortening and with mood disorders and schizophrenia (SZ). However, in previous post-mortem brain studies from occipital cortex and cerebellum, no difference in telomere length was observed in depression. We hypothesized that in psychiatric disorders, stress-driven accelerated cellular aging can be observed in brain regions particularly sensitive to stress. Telomere length was measured by quantitative-PCR in five brain regions (dorsolateral prefrontal cortex, hippocampus (HIPP), amygdala, nucleus accumbens and substantia nigra (SN)) in major depressive disorder (MDD), bipolar disorder, SZ and normal control subjects (N = 40, 10 subjects per group). We observed significant differences in telomere length across brain regions suggesting variable levels of cell aging, with SN and HIPP having the longest telomeres and the dorsolateral prefrontal cortex the shortest. A significant decrease (P < 0.02) in telomere length was observed specifically in the HIPP of MDD subjects even after controlling for age. In the HIPP of MDD subjects, several genes involved in neuroprotection and in stress response (FKBP5, CRH) showed altered levels of mRNA. Our results suggest the presence of hippocampal stress-mediated accelerated cellular aging in depression. Further studies are needed to investigate the cellular specificity of these findings.


Subject(s)
Depressive Disorder, Major/genetics , Depressive Disorder, Major/pathology , Hippocampus/pathology , Telomere/genetics , Telomere/pathology , Analysis of Variance , Brain/pathology , Cadaver , Dissection , Female , Genetic Techniques , Humans , Male , Middle Aged , Polymerase Chain Reaction
6.
Mol Psychiatry ; 20(1): 48-55, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25349171

ABSTRACT

Conventional antidepressants require 2-8 weeks for a full clinical response. In contrast, two rapidly acting antidepressant interventions, low-dose ketamine and sleep deprivation (SD) therapy, act within hours to robustly decrease depressive symptoms in a subgroup of major depressive disorder (MDD) patients. Evidence that MDD may be a circadian-related illness is based, in part, on a large set of clinical data showing that diurnal rhythmicity (sleep, temperature, mood and hormone secretion) is altered during depressive episodes. In a microarray study, we observed widespread changes in cyclic gene expression in six regions of postmortem brain tissue of depressed patients matched with controls for time-of-death (TOD). We screened 12 000 transcripts and observed that the core clock genes, essential for controlling virtually all rhythms in the body, showed robust 24-h sinusoidal expression patterns in six brain regions in control subjects. In MDD patients matched for TOD with controls, the expression patterns of the clock genes in brain were significantly dysregulated. Some of the most robust changes were seen in anterior cingulate (ACC). These findings suggest that in addition to structural abnormalities, lesion studies, and the large body of functional brain imaging studies reporting increased activation in the ACC of depressed patients who respond to a wide range of therapies, there may be a circadian dysregulation in clock gene expression in a subgroup of MDDs. Here, we review human, animal and neuronal cell culture data suggesting that both low-dose ketamine and SD can modulate circadian rhythms. We hypothesize that the rapid antidepressant actions of ketamine and SD may act, in part, to reset abnormal clock genes in MDD to restore and stabilize circadian rhythmicity. Conversely, clinical relapse may reflect a desynchronization of the clock, indicative of a reactivation of abnormal clock gene function. Future work could involve identifying specific small molecules capable of resetting and stabilizing clock genes to evaluate if they can rapidly relieve symptoms and sustain improvement.


Subject(s)
Antidepressive Agents/therapeutic use , CLOCK Proteins/genetics , Chronobiology Disorders/complications , Chronobiology Disorders/genetics , Depressive Disorder, Major , Animals , Depressive Disorder, Major/etiology , Depressive Disorder, Major/genetics , Depressive Disorder, Major/therapy , Excitatory Amino Acid Antagonists/therapeutic use , Gyrus Cinguli/metabolism , Humans , Ketamine/therapeutic use , Sleep Deprivation
7.
Mol Psychiatry ; 19(3): 334-41, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23459468

ABSTRACT

The kynurenine pathway metabolite kynurenic acid (KYNA), modulating glutamatergic and cholinergic neurotransmission, is increased in cerebrospinal fluid (CSF) of patients with schizophrenia or bipolar disorder type 1 with psychotic features. KYNA production is critically dependent on kynurenine 3-monooxygenase (KMO). KMO mRNA levels and activity in prefrontal cortex (PFC) are reduced in schizophrenia. We hypothesized that KMO expression in PFC would be reduced in bipolar disorder with psychotic features and that a functional genetic variant of KMO would associate with this disease, CSF KYNA level and KMO expression. KMO mRNA levels were reduced in PFC of bipolar disorder patients with lifetime psychotic features (P=0.005, n=19) or schizophrenia (P=0.02, n=36) compared with nonpsychotic patients and controls. KMO genetic association to psychotic features in bipolar disorder type 1 was studied in 493 patients and 1044 controls from Sweden. The KMO Arg(452) allele was associated with psychotic features during manic episodes (P=0.003). KMO Arg(452) was studied for association to CSF KYNA levels in an independent sample of 55 Swedish patients, and to KMO expression in 717 lymphoblastoid cell lines and 138 hippocampal biopsies. KMO Arg(452) associated with increased levels of CSF KYNA (P=0.03) and reduced lymphoblastoid and hippocampal KMO expression (P≤0.05). Thus, findings from five independent cohorts suggest that genetic variation in KMO influences the risk for psychotic features in mania of bipolar disorder patients. This provides a possible mechanism for the previous findings of elevated CSF KYNA levels in those bipolar patients with lifetime psychotic features and positive association between KYNA levels and number of manic episodes.


Subject(s)
Bipolar Disorder/genetics , Bipolar Disorder/metabolism , Kynurenic Acid/cerebrospinal fluid , Kynurenine 3-Monooxygenase/biosynthesis , Kynurenine 3-Monooxygenase/genetics , Psychotic Disorders/genetics , Psychotic Disorders/metabolism , Adult , Aged , Alleles , Bipolar Disorder/complications , Bipolar Disorder/diagnosis , Case-Control Studies , Cell Line , Female , Gene Expression , Genetic Predisposition to Disease/genetics , Hippocampus/metabolism , Humans , Male , Middle Aged , Prefrontal Cortex/metabolism , Psychotic Disorders/complications , Schizophrenia/cerebrospinal fluid , Schizophrenia/metabolism , Young Adult
9.
Mol Psychiatry ; 11(7): 615, 663-79, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16636682

ABSTRACT

Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders.


Subject(s)
Bipolar Disorder/metabolism , Brain/metabolism , Death , Depressive Disorder/metabolism , Gene Expression Regulation/physiology , Hydrogen-Ion Concentration , Mitochondria/metabolism , Neoplasm Proteins/genetics , Nerve Tissue Proteins/genetics , Antidepressive Agents/pharmacology , Apoptosis/genetics , Bipolar Disorder/drug therapy , Bipolar Disorder/genetics , Bipolar Disorder/pathology , Brain/drug effects , Brain/pathology , Cerebellum/drug effects , Cerebellum/metabolism , Cerebellum/pathology , DNA, Mitochondrial/genetics , DNA, Mitochondrial/metabolism , Depressive Disorder/genetics , Depressive Disorder/pathology , Female , Gene Dosage , Gene Expression Regulation/drug effects , Gyrus Cinguli/drug effects , Gyrus Cinguli/metabolism , Gyrus Cinguli/pathology , Humans , In Situ Hybridization , Lithium/pharmacology , Male , Middle Aged , Mitochondria/drug effects , Molecular Chaperones/biosynthesis , Molecular Chaperones/genetics , Neoplasm Proteins/biosynthesis , Nerve Tissue Proteins/biosynthesis , Oligonucleotide Array Sequence Analysis , Oxidative Stress/genetics , Polymerase Chain Reaction , Postmortem Changes , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Prefrontal Cortex/pathology , Proteasome Endopeptidase Complex/metabolism , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Selective Serotonin Reuptake Inhibitors/pharmacology , Time Factors
10.
Proc Natl Acad Sci U S A ; 102(43): 15653-8, 2005 Oct 25.
Article in English | MEDLINE | ID: mdl-16230605

ABSTRACT

Abnormalities in L-glutamic acid (glutamate) and GABA signal transmission have been postulated to play a role in depression, but little is known about the underlying molecular determinants and neural mechanisms. Microarray analysis of specific areas of cerebral cortex from individuals who had suffered from major depressive disorder demonstrated significant down-regulation of SLC1A2 and SLC1A3, two key members of the glutamate/neutral amino acid transporter protein family, SLC1. Similarly, expression of L-glutamate-ammonia ligase, the enzyme that converts glutamate to nontoxic glutamine was significantly decreased. Together, these changes could elevate levels of extracellular glutamate considerably, which is potentially neurotoxic and can affect the efficiency of glutamate signaling. The astroglial distribution of the two glutamate transporters and L-glutamate-ammonia ligase strongly links glia to the pathophysiology of depression and challenges the conventional notion that depression is solely a neuronal disorder. The same cortical areas displayed concomitant up-regulation of several glutamate and GABA(A) receptor subunits, of which GABA(A)alpha1 and GABA(A)beta3 showed selectivity for individuals who had died by suicide, indicating their potential utility as biomarkers of suicidality. These findings point to previously undiscovered molecular underpinnings of the pathophysiology of major depression and offer potentially new pharmacological targets for treating depression.


Subject(s)
Cerebral Cortex/metabolism , Depressive Disorder, Major/etiology , Glutamic Acid/physiology , Neuroglia/physiology , Signal Transduction , gamma-Aminobutyric Acid/physiology , Bipolar Disorder/etiology , Bipolar Disorder/metabolism , Depressive Disorder, Major/metabolism , Excitatory Amino Acid Transporter 1/genetics , Excitatory Amino Acid Transporter 2 , Gene Expression Profiling , Glutamate Plasma Membrane Transport Proteins/genetics , Glutamate-Ammonia Ligase/genetics , Humans , In Situ Hybridization , Oligonucleotide Array Sequence Analysis , Receptors, GABA-A/genetics
11.
Proc Natl Acad Sci U S A ; 101(43): 15506-11, 2004 Oct 26.
Article in English | MEDLINE | ID: mdl-15483108

ABSTRACT

In this report we describe findings that imply dysregulation of several fibroblast growth factor (FGF) system transcripts in frontal cortical regions of brains from human subjects with major depressive disorder (MDD). This altered gene expression was discovered by microarray analysis of frontal cortical tissue from MDD, bipolar, and nonpsychiatric control subjects and was verified by quantitative real-time PCR analysis and, importantly, in a separate cohort of MDD subjects. Furthermore, we show, through a separate analysis of specific serotonin reuptake inhibitor (SSRI)-treated and non-SSRI-treated MDD subjects that the observed changes in expression of FGF transcripts are not secondary to drug treatment. Rather, changes in specific FGF transcripts are attenuated by SSRIs and may thus be partially responsible for the mechanism of action of these drugs. We also make available the gene-expression profile of all of the other growth factors and growth factor receptors detected in these postmortem samples.


Subject(s)
Depressive Disorder, Major/physiopathology , Fibroblast Growth Factors/physiology , Adult , Aged , Aged, 80 and over , Depressive Disorder, Major/drug therapy , Female , Fibroblast Growth Factors/genetics , Humans , In Situ Hybridization , Male , Middle Aged , Oligonucleotide Array Sequence Analysis , Polymerase Chain Reaction , Selective Serotonin Reuptake Inhibitors/therapeutic use
12.
Neurobiol Dis ; 14(2): 240-50, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14572446

ABSTRACT

Transcriptional profiles within discrete human brain regions are likely to reflect structural and functional specialization. Using DNA microarray technology, this study investigates differences in transcriptional profiles of highly divergent brain regions (the cerebellar cortex and the cerebral cortex) as well as differences between two closely related brain structures (the anterior cingulate cortex and the dorsolateral prefrontal cortex). Replication of this study across three independent laboratories, to address false-positive and false-negative results using microarray technology, is also discussed. We find greater than a thousand transcripts to be differentially expressed between cerebellum and cerebral cortex and very few transcripts to be differentially expressed between the two neocortical regions. We further characterized transcripts that were found to be specifically expressed within brain regions being compared and found that ontological classes representing signal transduction machinery, neurogenesis, synaptic transmission, and transcription factors were most highly represented.


Subject(s)
Brain/metabolism , Gene Expression Profiling/methods , Oligonucleotide Array Sequence Analysis/methods , RNA/biosynthesis , Transcription, Genetic , Aged , Aged, 80 and over , Brain/pathology , Female , Humans , Male , Middle Aged , RNA/genetics
13.
Curr Mol Med ; 3(5): 437-46, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12942997

ABSTRACT

Neuropsychiatric disorders are generally diagnosed based on a classification of behavioral and, in some cases, specific neurological deficits. The lack of distinct quantitative and qualitative biological descriptors at the anatomical and cellular level complicates the search for and understanding of the neurobiology of these disorders. The advent of microarray technology has enabled large-scale profiling of transcriptional activity, allowing a comprehensive characterization of transcriptional patterns relating to the pathophysiology of neuropsychiatric disorders. We review some of the unique methodological constraints related to the use of human postmortem brain tissue in addition to the generally applicable requirements for microarray experiments. Microarray studies undertaken in neuropsychiatric disorders such as schizophrenia and substance abuse by the use of postmortem brain tissue indicate that transcriptional changes relating to synaptic function and plasticity, cytoskeletal function, energy metabolism, oligodendrocytes, and distinct intracellular signaling pathways are generally present. These have been supported by microarray studies in experimental models, and have produced multiple avenues to be explored at the functional level. The quality and specificity of information obtained from human postmortem tissue is rapidly increasing with the maturation and refinement of array-related methodologies and analysis tools, and with the use of focused cell populations. The development of experimental models of gene regulation in these disorders will serve as the initial step towards a comprehensive genome-linked analysis of the brain and associated disorders, and help characterize the integration and coordinate regulation of complex functions within the CNS.


Subject(s)
Oligonucleotide Array Sequence Analysis , Schizophrenia/genetics , Substance-Related Disorders/genetics , Gene Expression Profiling , Humans , Myelin Sheath/metabolism , RNA/metabolism , Schizophrenia/metabolism , Substance-Related Disorders/metabolism , Synapses/metabolism
14.
Pharmacogenomics J ; 3(1): 27-40, 2003.
Article in English | MEDLINE | ID: mdl-12629581

ABSTRACT

CNS-focused cDNA microarrays were used to examine gene expression profiles in dorsolateral prefrontal cortex (dlPFC, Area 46) from seven individual sets of age- and post-mortem interval-matched male cocaine abusers and controls. The presence of cocaine and related metabolites was confirmed by gas chromatography-mass spectrometry. Sixty-five transcripts were differentially expressed, indicating alterations in energy metabolism, mitochondria and oligodendrocyte function, cytoskeleton and related signaling, and neuronal plasticity. There was evidence for two distinct states of transcriptional regulation, with increases in gene expression predominating in subjects testing positive for a metabolite indicative of recent 'crack' cocaine abuse and decreased expression profiles in the remaining cocaine subjects. This pattern was confirmed by quantitative polymerase chain reaction for select transcripts. These data suggest that cocaine abuse targets a distinct subset of genes in the dlPFC, resulting in either a state of acute activation in which increased gene expression predominates, or a relatively destimulated, refractory phase.


Subject(s)
Cocaine-Related Disorders/genetics , Gene Expression Profiling/methods , Oligonucleotide Array Sequence Analysis/methods , Prefrontal Cortex/physiology , Transcriptional Activation/drug effects , Adult , Cluster Analysis , Crack Cocaine/adverse effects , Gene Expression Profiling/statistics & numerical data , Genotype , Humans , Male , Middle Aged , Oligonucleotide Array Sequence Analysis/statistics & numerical data , Polymerase Chain Reaction/methods , Transcription, Genetic/drug effects
15.
Mol Psychiatry ; 7(6): 571-8, 2002.
Article in English | MEDLINE | ID: mdl-12140780

ABSTRACT

Several studies suggest that decreased expression of presynaptic proteins may be characteristic of schizophrenia. We examined one such protein, synapsin, in schizophrenia and bipolar disorder. Samples of hippocampal tissue from controls (n = 13), patients with schizophrenia (n = 16), or bipolar disorder (n = 6), and suicide victims (n = 7) were used. The membrane and cytosolic fractions were analyzed by Western immunoblotting for synapsin using an antibody that detects synapsin Ia, IIa, and IIIa proteins. Synaptophysin was also measured for comparison. Total synapsin was decreased significantly in patients with schizophrenia (P = 0.034) and in bipolar disorder (P = 0.00008) as compared to controls. The synapsin/synaptophysin ratios were decreased in schizophrenia and bipolar disorder, and additionally in suicide victims (P = 0.014). Age, postmortem interval, percentage of protein extracted, and pH of brain were not different between groups. No changes in total synapsin or synaptophysin in the hippocampus were produced by injecting rats with either lithium or haloperidol for 30 days. Reductions in synapsin in both patients with schizophrenia (synapsin IIa and IIIa) and bipolar disorder (synapsin Ia, IIa and IIIa) imply that altered or reduced synaptic function in the hippocampus may be involved in these disorders.


Subject(s)
Bipolar Disorder/pathology , Hippocampus/metabolism , Schizophrenia/pathology , Synapsins/metabolism , Autopsy , Cause of Death , Female , Hippocampus/pathology , Humans , Male , Middle Aged , Reference Values , Suicide
16.
Neurobiol Dis ; 8(5): 822-33, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11592851

ABSTRACT

Due to brain tissue heterogeneity, the molecular genetic profile of any neurotransmitter-specific neuronal subtype is unknown. The purpose of this study was to purify a population of dopamine neurons, construct a cDNA library, and generate an initial gene expression profile and a microarray representative of dopamine neuron transcripts. Ventral mesencephalic dopamine neurons were purified by fluorescent-activated cell sorting from embryonic day 13.5 transgenic mice harboring a 4.5-kb rat tyrosine hydroxylase promoter-lacZ fusion. Nine-hundred sixty dopamine neuron cDNA clones were sequenced and arrayed for use in studies of gene expression changes during methamphetamine neurotoxicity. A neurotoxic dose of methamphetamine produced a greater than twofold up-regulation of the mitochondrial cytochrome c oxidase polypeptide I transcript from adult mouse substantia nigra at 12 h posttreatment. This is the first work to describe a gene expression profile for a neuronal subtype and to identify gene expression changes during methamphetamine neurotoxicity.


Subject(s)
Dopamine Uptake Inhibitors/toxicity , Dopamine/analysis , Electron Transport Complex IV/biosynthesis , Gene Expression Profiling , Gene Library , Methamphetamine/toxicity , Nerve Tissue Proteins/biosynthesis , Neurons/metabolism , Oligonucleotide Array Sequence Analysis , 3,4-Dihydroxyphenylacetic Acid/analysis , Animals , DNA, Complementary/genetics , Electron Transport Complex IV/genetics , Enzyme Induction , Female , Genes, Synthetic , Lac Operon , Male , Mesencephalon/cytology , Mesencephalon/embryology , Mice , Mice, Transgenic , Molecular Sequence Data , Nerve Tissue Proteins/genetics , Promoter Regions, Genetic , Rats , Transcription, Genetic , Tyrosine 3-Monooxygenase/genetics
17.
Exp Neurol ; 172(1): 29-46, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11681838

ABSTRACT

The neural cell adhesion molecule (N-CAM) is a cell recognition molecule involved in cellular migration, synaptic plasticity, and CNS development. A 105- to 115-kDa isoform of N-CAM (cleaved N-CAM or cN-CAM) is increased in schizophrenia in hippocampus, prefrontal cortex, and CSF. We purified and partially characterized cN-CAM, a putative novel isoform, and confirmed that the first 9 amino acids were identical to exon 1 of N-CAM, without the signal sequence. Analysis of trypsin-digested cN-CAM fragments by matrix-assisted laser desorption ionization on a time-of-flight mass spectrometer (MALDI-TOF) yielded peptides that could be identified as being derived from the first 548 amino acid residues of the expected N-CAM amino acid sequence. Immunological identification with four specific N-CAM antisera directed toward cytoplasmic, secreted, variable alternative spliced exon, or GPI epitopes failed to indicate other known splice variants. Neuraminidase treatment of cN-CAM produced a minor alteration resulting in a faster migrating immunoreactive band, indicating partial glycosylation of cN-CAM. Membranous particles from cytosolic brain extract containing cN-CAM were obtained by ultracentrifugation; however, CSF contained few such particles. cN-CAM and synaptophysin were colocalized on these particles. Both cN-CAM and N-CAM 180 were present in synaptosomal preparations of human brain. Following incubation of synaptosomes or brain tissue without protease inhibitors, N-CAM 180 was degraded and cN-CAM was increased. A cN-CAM-like band was present in human fetal neuronal cultures, but not in fetal astrocyte cultures. Thus, cN-CAM represents a protease- and neuraminidase-susceptible fragment possibly derived by proteolytic cleavage of N-CAM 180. An enlargement in ventricular volume in a group of adult patients with schizophrenia over a 2-year interval was found to be correlated with CSF cN-CAM levels as measured at the time of the initial MRI scan (r = 0.53, P = 0.01). cN-CAM is associated with ventricular enlargement; thus, the release of N-CAM fragments may be part of the pathogenic mechanism of schizophrenia in vulnerable brain regions such as the hippocampus and prefrontal cortex. Alternatively, the increases in cN-CAM in schizophrenia may be a reflection of a more general abnormality in the regulation of proteolysis or of extracellular matrix stability.


Subject(s)
Neural Cell Adhesion Molecules/chemistry , Neural Cell Adhesion Molecules/metabolism , Schizophrenia/metabolism , Adult , Alternative Splicing , Brain/metabolism , Cells, Cultured , Cerebrospinal Fluid/chemistry , Epitopes/metabolism , Female , Glycosylation , Humans , Immune Sera/metabolism , Male , Neural Cell Adhesion Molecules/genetics , Neuraminidase/metabolism , Peptide Fragments/chemistry , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , Sequence Analysis, Protein , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Subcellular Fractions/chemistry , Synaptosomes/chemistry , Synaptosomes/metabolism , Trypsin/metabolism
18.
Brain Res Bull ; 55(5): 641-50, 2001 Jul 15.
Article in English | MEDLINE | ID: mdl-11576761

ABSTRACT

Using cDNA microarrays we have investigated gene expression patterns in brain regions of patients with schizophrenia. A cDNA neuroarray, comprised of genes related to brain function, was used to screen pools of samples from the cerebellum and prefrontal cortex from a matched set of subjects, and middle temporal gyrus, from a separate subject cohort. Samples of cerebellum and prefrontal cortex from neuroleptic naive patients were also included. Genes that passed a 3% reproducibility criterion for differential expression in independent experiments included 21 genes for drug-treated patients and 5 genes for drug-naive patients. Of these 26 genes, 10 genes were increased and 16 were decreased. Many of the differentially expressed genes were related to synaptic signaling and proteolytic functions. A smaller number of these genes were also differentially expressed in the middle temporal gyrus. The five genes that were differentially expressed in two brain regions from separate cohorts are: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide; sialyltransferase; proteasome subunit, alpha type 1; ubiquitin carboxyl-terminal esterase L1; and solute carrier family 10, member 1. Identification of patterns of changes in gene expression may lead to a better understanding of the pathophysiology of schizophrenia disorders.


Subject(s)
Brain Chemistry/genetics , Brain/metabolism , Gene Expression Regulation/physiology , Oligonucleotide Array Sequence Analysis/trends , RNA, Messenger/analysis , Schizophrenia/genetics , Adult , Aged , Brain/pathology , Brain/physiopathology , Cerebellum/metabolism , Cerebellum/pathology , Cerebellum/physiopathology , Female , Genetic Testing , Humans , Male , Middle Aged , Oligonucleotide Array Sequence Analysis/methods , Prefrontal Cortex/metabolism , Prefrontal Cortex/pathology , Prefrontal Cortex/physiopathology , Reproducibility of Results , Schizophrenia/metabolism , Schizophrenia/pathology , Temporal Lobe/metabolism , Temporal Lobe/pathology , Temporal Lobe/physiopathology
19.
Brain Res ; 909(1-2): 194-203, 2001 Aug 03.
Article in English | MEDLINE | ID: mdl-11478936

ABSTRACT

Even though nicotine has been shown to modulate mRNA expression of a variety of genes, a comprehensive high-throughput study of the effects of nicotine on the tissue-specific gene expression profiles has been lacking in the literature. In this study, cDNA microarrays containing 1117 genes and ESTs were used to assess the transcriptional response to chronic nicotine treatment in rat, based on four brain regions, i.e. prefrontal cortex (PFC), nucleus accumbens (NAs), ventral tegmental area (VTA), and amygdala (AMYG). On the basis of a non-parametric resampling method, an index (called jackknifed reliability index, JRI) was proposed, and employed to determine the inherent measurement error across multiple arrays used in this study. Upon removal of the outliers, the mean correlation coefficient between duplicate measurements increased to 0.978+/-0.0035 from 0.941+/-0.045. Results from principal component analysis and pairwise correlations suggested that brain regions studied were highly similar in terms of their absolute expression levels, but exhibited divergent transcriptional responses to chronic nicotine administration. For example, PFC and NAs were significantly more similar to each other (r=0.7; P<10(-14)) than to either VTA or AMYG. Furthermore, we confirmed our microarray results for two representative genes, i.e. the weak inward rectifier K(+) channel (TWIK-1), and phosphate and tensin homolog (PTEN) by using real-time quantitative RT-PCR technique. Finally, a number of genes, involved in MAPK, phosphatidylinositol, and EGFR signaling pathways, were identified and proposed as possible targets in response to nicotine administration.


Subject(s)
Brain/drug effects , Gene Expression Regulation/drug effects , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Potassium Channels, Tandem Pore Domain , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Transcription, Genetic/drug effects , Tumor Suppressor Proteins , Amygdala/drug effects , Amygdala/metabolism , Animals , Brain/metabolism , Drug Administration Schedule , Gene Expression Regulation/physiology , Genes/drug effects , Genes/physiology , Male , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Oligonucleotide Array Sequence Analysis , PTEN Phosphohydrolase , Phosphoric Monoester Hydrolases/drug effects , Phosphoric Monoester Hydrolases/metabolism , Potassium Channels/drug effects , Potassium Channels/metabolism , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Rats , Rats, Sprague-Dawley , Reproducibility of Results , Signal Transduction/drug effects , Signal Transduction/physiology , Tobacco Use Disorder/genetics , Tobacco Use Disorder/metabolism , Tobacco Use Disorder/physiopathology , Transcription, Genetic/physiology , Ventral Tegmental Area/drug effects , Ventral Tegmental Area/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...